How many patents does
Icahn School Of Medicine At Mount Sinai have?
patents
1,399
families
218
granted
231
applications
1,168
US
381
WO
237
EP
214
JP
69
CN
65
KR
19
GB
3
RoW
411
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Icahn School Of Medicine At Mount Sinai
Top ten assignees appearing on patents
2009 - 2018
| alnylam pharmaceuticals | 54 |
| genzyme corporation | 27 |
| abbott | 13 |
| neurotrope bioscience | 9 |
| sideromics | 9 |
| celladon corporation | 8 |
| genisphere | 5 |
| abiomed | 2 |
| girihlet | 2 |
| merck & company | 2 |
2018
| alnylam pharmaceuticals | 13 |
| genzyme corporation | 3 |
| abiomed | 2 |
| merck & company | 2 |
| girihlet | 1 |
| molsoft | 1 |
| celladon corporation | 1 |
Icahn School Of Medicine At Mount Sinai
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| combination therapy for treating protein deficiency disorders | 66 | 2003 |
| attenuated negative strand viruses with altered interferon antagonist activity for use a… 🛈 | 47 | 1998 |
| compositions and methods for inhibiting expression of the alas1 gene | 38 | 2012 |
| dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency | 37 | 2009 |
| chimeric viruses presenting non-native surface proteins and uses thereof | 35 | 2005 |
| newcastle disease viruses and uses thereof | 31 | 2013 |
| derivatives of 1-deoxy-galactonojirimycin and their use in the treatment of lysosomal st… 🛈 | 28 | 1998 |
| compositions and methods for inhibiting expression of the alas1 gene | 26 | 2013 |
| influenza virus vaccines and uses thereof | 26 | 2012 |
| influenza virus vaccines and uses thereof | 22 | 2011 |